GL1X · GenesisL1 explorer

MolNFT v1 · #191391 · protein

Cryo-EM structure of SARS-cov-2 beta (B.1.351) spike protein in complex with vh domain F6 (focused refinement of rbd and vh F6)

8DI5 · Spike glycoprotein: “Cryo-EM structure of SARS-cov-2 beta (B.1.351) spike protein in complex with vh domain F6 (focused refinement…”. Electron microscopy, 1 ligand (NAG), 2 pockets (best druggability 0.46). MolNFT v1 #191391 on…

PDB
8DI5
Type
protein
Length
311 residues
Chains
2
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Spike glycoprotein; Vh F6
UniProt
P0DTC2
Ligands
NAG
Pockets
2 · best druggability 0.46

Structure

electron microscopy · 2 distinct chains · 12% helix, 36% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
CSpike glycoproteinprotein19514% helix, 28% strandP0DTC2
HVh F6protein1168% helix, 50% strand—

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · chains C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11430.460.7721empty
2840.340.7418empty

Interfaces

1 interface between chains.

  • C–H · 1007 Ų buried · 9 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 5 disulfide, 1 glycan (disulfide, N-glycosylation).

Compared structures

  • 8DI5 · Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein in complex with VH domain F6… · the same entry in another collection · chain C against C, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.